title: [Analysis of early and late results of progressive Graves-Basedow ophthalmopathy treatment with different methods].
abstract: The early (immediately after the end of treatment) and late (from 12 to 91, mean 46.3 months after the end of treatment) results of progressive Graves-Basedow ophthalmopathy treatment were evaluated in 71 patients (57 women and 14 men, aged 25-66, mean 47.3 years). In all patients the thorough ophthalmological evaluation was performed early and late after treatment and the abnormalities found were classified according to Werner's method and Donaldson's ophthalmopathy index. The patients were divided into 7 groups according to different methods of treatment. Groups I-V consisted of 31 patients treated with glucocorticoids or glucocorticoids with azathioprine (Imuran) in the first stage of medication (30 patients). Plasmapheresis (7 patients) or tele-cobalt irradiation (3 patients) was applied as the second stage of treatment when the first stage was ineffective. In one person plasmapheresis and tele-cobalt irradiation was applied without previous glucocorticoid therapy. Two patients were treated successively by glucocorticoids, plasmapheresis and tele-cobalt irradiation. Very good and good late results of treatment were found in 95% of patients out of 22 reexamined persons of groups 1-5. Group 6 consisted of 7 patients treated with cobalt irradiation alone, in all 6 patients evaluated late results were good or very good. Out of 33 patients of group 7 treated by combination of glucocorticoids and telecobalt irradiation 23 were evaluated late and the results were found good or very good in 96%. The results suggest that combined treatment of progressive endocrine ophthalmopathy with glucocorticoids and cobalt irradiation is the most effective method of treatment at present. The affectivity of stage treatment is comparable with combined treatment but lasts longer and usually is more expansive.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Kliniki Endokrynologii i Chorób Przemiany Materii, Szczecinie.
authors.forename: K
authors.initials: K
authors.lastname: Pilarska
authors.forename: S
authors.initials: S
authors.lastname: Czekalski
authors.forename: A
authors.initials: A
authors.lastname: Syrenicz
authors.forename: W
authors.initials: W
authors.lastname: Andrzejewska
authors.forename: Z
authors.initials: Z
authors.lastname: Krzystolik
authors.forename: D
authors.initials: D
authors.lastname: Przerwa
mesh_terms: D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005128:Eye Diseases / Q000628:therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006111:Graves Disease / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011867:Radioisotope Teletherapy
chemical_list: D003037:Cobalt Radioisotopes; D005938:Glucocorticoids; D001379:Azathioprine
vernacular_title: Analiza wstepnych i odległych wyników leczenia oftalmopatii obrzekowo-naciekowej w chorobie Gravesa-Basedowa róznymi metodami.